Mizuho Securities Co. Ltd. Amgen Inc Transaction History

Mizuho Securities Co. Ltd.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 24, 2023	BUY	$225.79 - $275.2 $6,773 - $8,256	30 New	30 $7,000
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $224 - $253	1 Added 4.0%	26 $6,000
Q2 2022 Jul 21, 2022	SELL	$230.71 - $256.74 $230 - $256	-1 Reduced 3.85%	25 $6,000
Q4 2021 Feb 04, 2022	SELL	$198.88 - $227.6 $7,955 - $9,104	-40 Reduced 60.61%	26 $6,000
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $8,490 - $9,948	40 Added 153.85%	66 $14,000
Q2 2021 Aug 05, 2021	SELL	$233.58 - $259.14 $233 - $259	-1 Reduced 3.7%	26 $6,000
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $1,775 - $2,068	-8 Reduced 22.86%	27 $7,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $7,573 - $9,018	35 New	35 $8,000
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $25,005 - $29,311	-150 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $27,130 - $30,582	-150 Reduced 50.0%	150 $28,000
Q4 2018 Feb 13, 2019	BUY	$178.4 - $208.25 $53,520 - $62,475	300 New	300 $58,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.